CTT PHARMACEUTICAL HOLDINGS, INC. purchased $114 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-15.
CTT PHARMACEUTICAL HOLDINGS, INC.
No enriched coverage for $CTTH in the last 7 days.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-15.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-06.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
Recent CTTH coverage spans insider activity and corporate actions.
In the last 30 days, CTTH insiders filed 4 SEC Form 4 transactions — 4 purchases ($959) and no sales. The most active reporter was CTT PHARMACEUTICAL HOLDINGS, INC., CEO, with 4 filings.
Minor positive pressure as insider buying signals confidence, but size is negligible.
Small insider buy by the CEO may signal confidence but the monetary amount is negligible.
Minor insider purchase likely signals confidence but size is negligible.
Board appointment may improve governance and strategic oversight.
Small insider purchase signals confidence but size is negligible for price.
AlphAI scores every news story that mentions CTTH with an AI model for sentiment and relevance, and aggregates insider trades from CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 2,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-15.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-06.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,400 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-09-28.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 8.01 Other Events. CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen cre
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,100 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.04 on 2026-09-22.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,900 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-16.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-10.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 9,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-04.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-02.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,500 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-08-31.
1 min read